SOTYKTU 6 mg/1 (Deucravacitinib TABLET, FILM COATED) 6 mg/1

SOTYKTU 6 mg/1 is a medication containing deucravacitinib, used for managing specific inflammatory conditions. This oral tablet is designed to help alleviate symptoms and improve quality of life.

Strength

6 mg/1

Pack Size

30 TABLET, FILM COATED in 1 BLISTER PACK (0003-0895-91)

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SOTYKTU 6 mg/1 is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Deucravacitinib, the active ingredient, works by targeting specific pathways involved in inflammation. Patients often wonder, 'What is SOTYKTU used for?' It is generally prescribed for conditions where inflammation plays a key role.

Side Effects

Common effects of SOTYKTU 6 mg/1 may include nausea, diarrhea, and upper respiratory tract infections. Some users might experience fatigue or headaches. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

SOTYKTU 6 mg/1 should be handled with care, especially for those with a history of severe infections or blood clots. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication as directed to maintain its effectiveness.

Avoid Interactions

SOTYKTU 6 mg/1 may interact with certain medications, including those that affect the immune system or blood clotting. Alcohol and other substances that suppress the immune system should be used with caution. Always consult a healthcare provider before combining SOTYKTU with other treatments.

Frequently Asked Questions

SOTYKTU 6 mg/1 is used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

SOTYKTU 6 mg/1 is taken orally, typically once daily. Follow the instructions provided by your healthcare provider for the best results.

Common side effects may include nausea, diarrhea, upper respiratory tract infections, fatigue, and headaches.

It is advisable to consult your healthcare provider before consuming alcohol while taking SOTYKTU, as it may interact with the medication.

Store SOTYKTU 6 mg/1 at room temperature, away from moisture and heat, and keep it out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.